About Diagenode
Diagenode is a company based in Seraing (Belgium) founded in 2003 was acquired by Hologic in March 2021.. Diagenode has raised $8.45 million across 12 funding rounds from investors including Hologic, European Union and Capricorn Partners. The company has 99 employees as of March 31, 2020. Diagenode has completed 1 acquisition, including NXT-Dx. Diagenode operates in a competitive market with competitors including Arbor Biotechnologies, Sino Biological, Singleron, GenScript and OncoDNA, among others.
- Headquarter Seraing, Belgium
- Employees 99 as on 31 Mar, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Diagenode
-
Annual Revenue
$19.53 M (USD)9as on Mar 31, 2020
-
Net Profit
$-1 M (USD)-452as on Mar 31, 2020
-
EBITDA
-
Total Equity Funding
$8.45 M (USD)
in 12 rounds
-
Latest Funding Round
$117.75 K (USD), Grant
Sep 01, 2019
-
Investors
Hologic
& 5 more
-
Employee Count
99
as on Mar 31, 2020
- Investments & Acquisitions
-
Acquired by
Hologic
(Mar 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Diagenode
Diagenode has successfully raised a total of $8.45M across 12 strategic funding rounds. The most recent funding activity was a Grant round of $117.75 thousand completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Grant — $117,749
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Grant - Diagenode | Valuation |
investors |
|
| Jul, 2019 | Amount | Grant - Diagenode | Valuation |
investors |
|
| Jun, 2019 | Amount | Grant - Diagenode | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Diagenode
Diagenode has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Hologic, European Union and Capricorn Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Buyouts are pursued by SRIW as a private equity firm.
|
Founded Year | Domain | Location | |
|
Investments are directed by Capricorn Partners into European tech ventures.
|
Founded Year | Domain | Location | |
|
Épimède is engaged in investing in high-growth technological SMEs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Diagenode
Diagenode has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NXT-Dx. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Epigenetics services are offered to life science researchers.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Diagenode
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Diagenode Comparisons
Competitors of Diagenode
Diagenode operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Arbor Biotechnologies, Sino Biological, Singleron, GenScript and OncoDNA, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic technologies and drug discovery platforms are provided.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Genomic and theranostic services for oncology precision medicine are delivered.
|
|
| domain | founded_year | HQ Location |
Proprietary reagents for single-cell genetic analysis are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Diagenode
Frequently Asked Questions about Diagenode
When was Diagenode founded?
Diagenode was founded in 2003 and raised its 1st funding round 11 years after it was founded.
Where is Diagenode located?
Diagenode is headquartered in Seraing, Belgium. It is registered at Seraing, Liege, Belgium.
Is Diagenode a funded company?
Diagenode is a funded company, having raised a total of $8.45M across 12 funding rounds to date. The company's 1st funding round was a Grant of $287.04K, raised on Jun 01, 2014.
How many employees does Diagenode have?
As of Mar 31, 2020, the latest employee count at Diagenode is 99.
What is the annual revenue of Diagenode?
Annual revenue of Diagenode is $19.53M as on Mar 31, 2020.
What does Diagenode do?
Diagenode develops epigenetics solutions and services for life science research. Its flagship product IP-Star Compact is an automated bench-top solution for high-throughput epigenetic sequencing. It has automated protocols for chromatin immunoprecipitation (ChIP), methylated DNA immunoprecipitation (MeDIP), hydroxymethylated DNA immunoprecipitation (hMeDIP), methyl-binding domain protein capture assays (MethylCap), sequential ChIP (Re-ChIP), bisulfite conversion and DNA immunoprecipitation (RNA-IP). In addition, the company provides epigenetic sequencing services, reagents, kits, bioinformatics software associated with IP-Star.
Who are the top competitors of Diagenode?
Diagenode's top competitors include Arbor Biotechnologies, Sino Biological and OncoDNA.
How many acquisitions has Diagenode made?
Diagenode has made 1 acquisition, including NXT-Dx.
Who are Diagenode's investors?
Diagenode has 6 investors. Key investors include Hologic, European Union, Capricorn Partners, SRIW, and Ostbelgieninvest.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.